{"id":"https://openalex.org/W2552978108","doi":"https://doi.org/10.3324/haematol.2016.150656","title":"The emerging role of immune checkpoint inhibition in malignant lymphoma","display_name":"The emerging role of immune checkpoint inhibition in malignant lymphoma","alternate_titles":[],"publication_year":2016,"publication_date":"2016-11-24","ids":{"openalex":"https://openalex.org/W2552978108","doi":"https://doi.org/10.3324/haematol.2016.150656","mag":"2552978108","pmid":"https://pubmed.ncbi.nlm.nih.gov/27884973","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5210230"},"language":"en","primary_location":{"id":"doi:10.3324/haematol.2016.150656","doi":"https://doi.org/10.3324/haematol.2016.150656","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2016.150656","pdf_url":null,"source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2552978108"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3324/haematol.2016.150656","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085373822","display_name":"Ida Hude","orcid":"https://orcid.org/0000-0001-5527-0647","observed_orcids":["https://orcid.org/0000-0001-5527-0647"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]}],"countries":["HR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ida Hude","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology, University Hospital Center Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology, University Hospital Center Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059416243","display_name":"Stephanie Sasse","orcid":"https://orcid.org/0000-0002-1080-4606","observed_orcids":["https://orcid.org/0000-0002-1080-4606"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephanie Sasse","raw_affiliation_strings":["Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057387418","display_name":"Andreas Engert","orcid":"https://orcid.org/0000-0002-1890-1523","observed_orcids":["https://orcid.org/0000-0002-1890-1523"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andreas Engert","raw_affiliation_strings":["Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061291419","display_name":"Paul Jan Br\u00f6ckelmann","orcid":"https://orcid.org/0000-0001-9662-9900","observed_orcids":["https://orcid.org/0000-0001-9662-9900"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul J. Br\u00f6ckelmann","raw_affiliation_strings":["Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany paul.broeckelmann@uk-koeln.de","Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany paul.broeckelmann@uk-koeln.de","institution_ids":["https://openalex.org/I4210153755"]},{"raw_affiliation_string":"Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2000,"currency":"EUR","value_usd":2157},"apc_paid":{"value":2000,"currency":"EUR","value_usd":2157},"fwci":16.5162,"has_fulltext":false,"cited_by_count":114,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99323054,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"102","issue":"1","first_page":"30","last_page":"42"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7764000296592712,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7764000296592712,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.21850000321865082,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.9679999947547913},{"id":"https://openalex.org/keywords/pdcd1","display_name":"PDCD1","score":0.8100000023841858},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/classical-hodgkin-lymphoma","display_name":"classical Hodgkin lymphoma","score":0.9750000238418579},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9559999704360962},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6610000133514404},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8930000066757202},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9490000009536743}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8192589282989502},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6798427104949951},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6440379619598389},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6357033848762512},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5814787745475769},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5612068176269531},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.554731011390686},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45671501755714417},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4538489580154419},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.43555518984794617},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41512805223464966},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3205416798591614}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056747","descriptor_name":"Immunomodulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.3324/haematol.2016.150656","doi":"https://doi.org/10.3324/haematol.2016.150656","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2016.150656","pdf_url":null,"source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4130079","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5210230","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5210230","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5210230/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"Text"},{"id":"pmid:27884973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27884973","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"Journal Article"},{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:24342","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/24342/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:article"},{"id":"pmh:oai:doaj.org/article:a10057ba474c4d79bd63109c664219b7","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/a10057ba474c4d79bd63109c664219b7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematologica, Vol 102, Iss 1 (2017)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3324/haematol.2016.150656","doi":"https://doi.org/10.3324/haematol.2016.150656","is_oa":true,"landing_page_url":"https://doi.org/10.3324/haematol.2016.150656","pdf_url":null,"source":{"id":"https://openalex.org/S2752781272","display_name":"Haematologica","issn_l":"0390-6078","issn":["0390-6078","1592-8721"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317774","host_organization_name":"Ferrata Storti Foundation","host_organization_lineage":["https://openalex.org/P4310317774"],"host_organization_lineage_names":["Ferrata Storti Foundation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310646","display_name":"European Hematology Association","ror":"https://ror.org/05hk0hn26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":101,"referenced_works":["https://openalex.org/W94592798","https://openalex.org/W1135493307","https://openalex.org/W1510649334","https://openalex.org/W1556990476","https://openalex.org/W1605230984","https://openalex.org/W1824887649","https://openalex.org/W1856646401","https://openalex.org/W1910012553","https://openalex.org/W1953890763","https://openalex.org/W1973701944","https://openalex.org/W1974307608","https://openalex.org/W1981989535","https://openalex.org/W1985563120","https://openalex.org/W1986354050","https://openalex.org/W1992519684","https://openalex.org/W1993864112","https://openalex.org/W2006091295","https://openalex.org/W2008577378","https://openalex.org/W2010105078","https://openalex.org/W2011228017","https://openalex.org/W2014789164","https://openalex.org/W2016983859","https://openalex.org/W2020586896","https://openalex.org/W2034751554","https://openalex.org/W2035852466","https://openalex.org/W2040596212","https://openalex.org/W2040839982","https://openalex.org/W2047902191","https://openalex.org/W2048797618","https://openalex.org/W2051830227","https://openalex.org/W2062486240","https://openalex.org/W2065386296","https://openalex.org/W2066607092","https://openalex.org/W2067948267","https://openalex.org/W2073125824","https://openalex.org/W2075736621","https://openalex.org/W2078531506","https://openalex.org/W2085257327","https://openalex.org/W2097995306","https://openalex.org/W2100158834","https://openalex.org/W2101996346","https://openalex.org/W2105396178","https://openalex.org/W2107150019","https://openalex.org/W2115091768","https://openalex.org/W2117613554","https://openalex.org/W2121770645","https://openalex.org/W2123363005","https://openalex.org/W2124427232","https://openalex.org/W2125616358","https://openalex.org/W2130473166","https://openalex.org/W2131234364","https://openalex.org/W2132598458","https://openalex.org/W2133201432","https://openalex.org/W2135215267","https://openalex.org/W2135737755","https://openalex.org/W2140521865","https://openalex.org/W2140875987","https://openalex.org/W2142014345","https://openalex.org/W2142604595","https://openalex.org/W2144129204","https://openalex.org/W2147240268","https://openalex.org/W2152897456","https://openalex.org/W2155256323","https://openalex.org/W2155464214","https://openalex.org/W2155654588","https://openalex.org/W2160834915","https://openalex.org/W2163401417","https://openalex.org/W2164433065","https://openalex.org/W2165456770","https://openalex.org/W2165983948","https://openalex.org/W2166662937","https://openalex.org/W2171741398","https://openalex.org/W2171771895","https://openalex.org/W2173274196","https://openalex.org/W2175254188","https://openalex.org/W2177405394","https://openalex.org/W2185075416","https://openalex.org/W2278440281","https://openalex.org/W2321985702","https://openalex.org/W2327505660","https://openalex.org/W2337659275","https://openalex.org/W2412725897","https://openalex.org/W2414282448","https://openalex.org/W2416231044","https://openalex.org/W2473498748","https://openalex.org/W2508264364","https://openalex.org/W2510562806","https://openalex.org/W2519408114","https://openalex.org/W2524659632","https://openalex.org/W2524916302","https://openalex.org/W2546779013","https://openalex.org/W2560367415","https://openalex.org/W2572174216","https://openalex.org/W2578355253","https://openalex.org/W2578673067","https://openalex.org/W2745585526","https://openalex.org/W2751965733","https://openalex.org/W2890930358","https://openalex.org/W2891068880","https://openalex.org/W3152998583","https://openalex.org/W4249076734"],"related_works":["https://openalex.org/W2935906001","https://openalex.org/W2538110829","https://openalex.org/W2955495500","https://openalex.org/W2588343726","https://openalex.org/W3030343867","https://openalex.org/W3046053699","https://openalex.org/W2254218707","https://openalex.org/W2783314963","https://openalex.org/W3154155717","https://openalex.org/W4213353878"],"abstract_inverted_index":{"To":[0,79],"evade":[1],"elimination":[2],"by":[3,139],"the":[4,25,36,84,119,130,140,153,156],"host":[5],"immune":[6,13,19,39,121,190],"system,":[7],"tumor":[8,29],"cells":[9,30],"commonly":[10],"exploit":[11],"physiological":[12],"checkpoint":[14,40,122,163,191],"pathways,":[15],"restraining":[16],"efficient":[17],"anti-tumor":[18],"cell":[20],"function.":[21],"Growing":[22],"understanding":[23],"of":[24,38,72,86,132,155,162],"complex":[26],"dialog":[27],"between":[28],"and":[31,58,74,98,114,142,159,182],"their":[32],"microenvironment":[33],"contributed":[34],"to":[35,171],"development":[37],"inhibitors.":[41],"This":[42],"innovative":[43],"strategy":[44],"has":[45],"demonstrated":[46],"paradigm-shifting":[47],"clinical":[48,175],"activity":[49,73],"in":[50,66,83,105,111,124,145,165],"various":[51,166],"malignancies.":[52,168],"Antibodies":[53],"targeting":[54],"programmed":[55],"death":[56,92],"1":[57,93],"cytotoxic":[59],"T-lymphocyte-associated":[60],"protein-4":[61],"are":[62,193],"also":[63,110],"being":[64],"investigated":[65],"lymphoid":[67,167],"malignancies":[68],"with":[69,189],"varying":[70],"levels":[71],"a":[75],"favorable":[76],"toxicity":[77],"profile.":[78],"date,":[80],"evaluated":[81],"only":[82],"setting":[85],"relapsed":[87,133],"or":[88,134],"refractory":[89,135],"disease,":[90],"anti-programmed":[91],"antibodies":[94],"such":[95],"as":[96],"nivolumab":[97,126],"pembrolizumab":[99],"show":[100],"encouraging":[101],"response":[102],"rates":[103],"particularly":[104],"classical":[106,136],"Hodgkin":[107,137],"lymphoma":[108,113,138],"but":[109],"follicular":[112],"diffuse-large":[115],"B-cell":[116],"lymphoma.":[117],"As":[118],"first":[120],"inhibitor":[123],"lymphoma,":[125],"was":[127],"approved":[128],"for":[129],"treatment":[131],"Food":[141],"Drug":[143],"Administration":[144],"May":[146],"2016.":[147],"In":[148,169],"this":[149],"review,":[150],"we":[151],"assess":[152],"role":[154],"pathways":[157],"involved":[158],"potential":[160,180],"rationale":[161],"inhibition":[164,192],"addition":[170],"data":[172],"from":[173],"current":[174],"trials,":[176],"immune-related":[177],"side":[178],"effects,":[179],"limitations":[181],"future":[183],"perspectives":[184],"including":[185],"promising":[186],"combinatory":[187],"approaches":[188],"discussed.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2552978108","counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":26},{"year":2017,"cited_by_count":17}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-11-30T00:00:00"}
